In this special Tokyo edition of the Making Medicine Podcast, John Stanford hosts a powerhouse panel of biotech investors, founders, and industry leaders to break down Japan’s emerging life-sciences boom. Together, they explore Japan’s regulatory shifts, government incentives, and rising startup momentum. This episode unpacks how Japan is positioning itself as a global hub for regenerative medicine, gene therapy, and bioeconomy innovation. Whether you're a policymaker, entrepreneur, or simply curious about global biotech trends, you'll get a front-row seat to Japan’s life sciences ecosystem, and why the rest of the world is watching.

What part of Japan’s biotech ecosystem surprised you the most?
Do you think global biotech companies should be paying more attention to Japan? Why or why not? Where do you see the biggest opportunity for Japan to lead in biotech?

If you're new to the Making Medicine Podcast, we're happy you're here! Follow us for more: https://x.com/MakingMedPod https://www.instagram.com/makingmedicinepod/ https://www.linkedin.com/showcase/making-medicine-podcast/about/?viewAsMember=true

Time Stamps:
0:00 Introduction: Why We’re Recording in Tokyo
2:45 Japan’s Biotech Vision: From Strategy to Reality
6:10 Role of Government & Public-Private Partnerships
9:20 Innovation Hubs: Shared Labs & Incubators
12:05 Investment Landscape: VCs, Funds & Incentives
15:30 Regenerative Medicine & iPSC Development
18:45 Gene & Cell Therapy Trends in Japan
22:00 Regulatory Reform & Drug Approval Acceleration
24:45 Global Biotech Partnerships: Japan’s Reach Abroad
27:10 Challenges: From Risk-Averse Culture to Commercialization
29:50 The Bioeconomy: Beyond Pharmaceuticals
32:15 What’s Next: Predictions for Japan’s Biotech Future

DISCLAIMER: We’re reporting on the headlines, not making medical recommendations. For personal health questions, always consult a doctor.